In general, contacts between the IFP and potential customers are made at scientific conferences. The Institute's reputation and the patents it has filed (which are public) mean that buyers know to which areas of the IFP's work they can have access. The IFP does not engage in canvassing to set up contracts for collaboration or to sell licences but operates a network of offices and agents which promote its research work.
Research findings are transferred to firms in four different ways: (a) dissemination in the public domain; (b) individualized services; (c) exploitation of collaborative research; (d) sales of licences.
Dissemination in the public domain concerns fundamental research or basic industrial research which has been published. Such research is accessible to all, especially since some of the publications are in English.
Individualized services: in this case, all findings are communicated to the buyer. Such transfers are carried out on an exclusive, full-ownership basis. The IFP may even be prohibited from using knowledge thus acquired for an agreed period. The work is invoiced at cost price as calculated from the accounts. These services are available to any interested company.
Collaborative research is the most usual form of transfer. The expenditure incurred by each partner is recorded on presentation of invoices for external expenditure and by applying rates reflecting all staff costs and overheads to time spent. This is carried out under the supervision and subject to the approval of an auditor in accordance with the rules of ordinary law. It should be noted that depreciation is not taken into account when the IFP's expenditure is calculated.
Joint ownership of findings is proportionate to the respective shares in financing, and the allocation of the rights of exploitation includes the option of transferring licences to third parties against payment.
The transfer of licences concerns both the IFP's own research and collaborative research. Total transfers of research findings do not occur (no sales of patents but merely of licences to exploit the findings). User rights are limited over time and geographically. The IFP and its partners remain free to grant licences to other firms.